MedTrace Logo

ACUVUE® OASYS With Transitions™ Light Intelligent Technology™ Clinical Performance Registry

NCT04116736 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2025-05-23

Study results available
· View outcomes & findings →

Summary

This registry study is a one-year, one-visit, observational, prospective, open-label, two-arm, multi-center, multi-national, post-market study of approximately 300 patients who have recently been fitted with the ACUVUE® OASYS with Transitions™ and approximately 300 patients who have recently been fitted with spherical nonphotochromic reusable marketed silicone hydrogel contact lenses (of any brand). Eligible subjects will be asked to complete a Patient Registration Questionnaire several times throughout the year.

Conditions

  • Vision Satisfaction in Bright Light

Interventions

DEVICE

ACUVUE® OASYS with Transitions™

JJVC Marketed Contact Lens

DEVICE

Silicone Hydrogel Contact Lens

Any reusable spherical silicone hydrogel brand that is approved and marketed in the country conducting the study.

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Vision Care, Inc Clinical Trial · Johnson & Johnson Vision Care, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-19
Primary Completion
2023-03-10
Completion
2023-03-10
FDA Device
Yes

Countries

  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04116736 on ClinicalTrials.gov